Your Guide to Bone Mets: The Basics
Today’s episode is the first in a three part series covering all things related to bone metastasis. In our first episode, we’re covering the basics starting with some bone education. We’re joined by Dr. Azeez Farooki, an endocrinologist at MSK, who discusses his role on treatment for bone disease stemming from breast cancer. We’re also joined by Dr. Monica Fornier, a breast medical oncologist also at MSK, who treats people living with metastatic breast cancer. Both doctors will be diving into bone disease & the latest in breast cancer bone metastasis research. Topics include theories on why breast cancer spreads to the bones, as well as the future of bone metastasis research and treatment. We unlock the wisdom of these top experts as they bridge the gaps between advancing research and patient care in a thought provoking conversation.
Meet the Guests of the Episode
Monica Fornier, MD
Dr. Fornier is an Associate Member of the Breast Medicine Service of Memorial Sloan Kettering Cancer Center, and an Associate Professor at Weill Cornell Medical College.
She specializes in the treatment of patients with breast carcinoma as well as bone health: she conducts clinical research, with particular regard to novel strategies for the preservation of bone health for both patients with early stage and metastatic disease. In this regard, she collaborates with scientists from Hospital of Special Surgery in NY, as well as other academic institutions.
Dr. Fornier is an active member of various national and international scientific groups, including the American Society of Clinical Oncology, the European Society of Medical Oncology, The American Society of Bone and Mineral Research and the International Osteoporosis Foundation. Dr. Fornier has numerous publications to her name and has presented data at several meetings.
Azeez Farooki, MD
Dr. Farooki is an endocrinologist with particular interest in bone metabolism in people with cancer. He sees both patients with benign metabolic bone diseases, such as osteoporosis and hyperparathyroidism, and bone disorders due to advanced cancer, such as hypercalcemia and metastatic bone disease.
Much of Dr. Farooki’s research has focused on rare complications of a subset of bone protective drugs known as antiresorptives. He has twice served on the National Comprehensive Cancer Care Network’s Bone Health in Cancer Care task force.
